|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03692 HANSOH PHARMA
Nominal 
16.060 -0.300 (-1.834%) | 2021/12 - Final RMB(K¥) | %Chg (Final to Final) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | 2017/12 RMB(K¥) | ||
| Turnover | 9,935,141 | 14.325% | 8,690,234 | 8,682,746 | 7,722,278 | 6,185,537 | |
| Cost of Sales | (870,042) | 8.543% | (801,561) | (729,540) | (603,100) | (455,171) | |
| Gross Profit | 9,065,099 | 14.913% | 7,888,673 | 7,953,206 | 7,119,178 | 5,730,366 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 3,300,082 | 6.513% | 3,098,299 | 3,000,925 | 2,309,325 | 1,932,791 | |
| Taxation | (587,180) | 10.916% | (529,392) | (444,183) | (406,277) | (337,318) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,712,902 | 5.605% | 2,568,907 | 2,556,742 | 1,903,048 | 1,595,473 | |
| Net Finance Costs / (Income) | (111,275) | 23.103% | (90,392) | (153,459) | (2,853) | (1,597) | |
| Depreciation & Amortisation | 278,467 | 19.373% | 233,274 | 201,554 | 159,096 | 138,013 | |
| Directors' Emoluments | -- | -- | 38,207 | 39,937 | 36,325 | 25,431 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 46.000 | -- | 44.000 | 47.000 | 38.000 | -- |
| DPS (cts) | 7.320 | -- | 6.510 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | 15.913% | -- | 14.795% | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.407 | 0.608 | 0.414 | -- |
| NBV per share ($) | 3.382 | -- | 3.020 | 2.253 | -- | -- |
| Remarks: | Real time quote last updated: 05/07/2022 11:21 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,712,902 |
| %Change | 5.605% |
| EPS / (LPS) | RMB 0.460 |
| NBV Per Share (¥) | RMB 3.382 |